UBS Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.9M Sell
1,529,542
-1,275,773
-45% -$83.9M 0.01% 1137
2026
Q1
$200M Sell
2,805,315
-42,397
-1% -$3.34M 0.03% 616
2025
Q4
$234M Buy
2,847,712
+1,057,594
+59% +$82.4M 0.04% 502
2025
Q3
$134M Sell
1,790,118
-1,215,260
-40% -$90.6M 0.02% 818
2025
Q2
$223M Buy
3,005,378
+487,977
+19% +$34M 0.04% 488
2025
Q1
$203M Sell
2,517,401
-1,441,148
-36% -$124M 0.04% 493
2024
Q4
$309M Buy
3,958,549
+2,415,990
+157% +$205M 0.06% 319
2024
Q3
$145M Buy
1,542,559
+100,050
+7% +$8.4M 0.03% 549
2024
Q2
$112M Buy
1,442,509
+158,241
+12% +$12.9M 0.03% 592
2024
Q1
$117M Buy
1,284,268
+241,970
+23% +$20.1M 0.03% 578
2023
Q4
$80.6M Buy
1,042,298
+16,372
+2% +$1.15M 0.02% 692
2023
Q3
$69.8M Buy
1,025,926
+68,762
+7% +$5M 0.02% 652
2023
Q2
$77.8M Buy
957,164
+307,017
+47% +$24.5M 0.03% 600
2023
Q1
$53.3M Buy
650,147
+650,076
+915,600% +$46.4M 0.02% 746
2022
Q4
$4.14K Buy
+71
New +$4.09K ﹤0.01% 9377

Other funds holding GEHC

UBS Group's GEHC Position: Q2 2026 in Review

UBS Group reduced its GE HealthCare (GEHC) stake by 45% in Q2 2026, selling an estimated $83.9M and leaving 1,529,542 shares worth $97.9M. The position accounts for 0.01% of the portfolio, ranked #1137.

UBS Group first reported a position in GEHC in Q4 2022 and has held it in 15 quarters since. The position peaked at $309M in Q4 2024. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • UBS Group held 1,529,542 shares of GE HealthCare worth $97.9M as of Q2 2026.
  • UBS Group sold 1,275,773 GE HealthCare shares in Q2 2026, an estimated $83.9M.
  • GE HealthCare made up 0.01% of UBS Group's portfolio in Q2 2026, its #1137 holding.
  • UBS Group first reported a position in GE HealthCare in Q4 2022 and has held it in 15 quarters since.
  • UBS Group's GE HealthCare position peaked at $309M in Q4 2024.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.